Entera Bio ENTX
NASDAQ ENTX
$3.22 -0.02 (-0.62%)
At close: Nov 11, 2026 · 4:00 PM EST

Entera Bio (ENTX) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Entera Bio's Return on Capital Employed [ROCE] was -101.62% in Q2 2026, down 45.27 percentage points from -56.36% a year earlier and down 5.08 percentage points from the prior quarter.

Analysis

Entera Bio (ENTX) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Entera Bio came in at -109.92%, down 7.97 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has now declined for three consecutive years, with a five-year change of -11.71 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -101.95% in FY2024 (-23.65 pp), -78.30% in FY2023 (-6.84 pp), -71.46% in FY2022 (+11.69 pp) and -83.15% in FY2021 (+15.06 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] since Q4 2024.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in five of the last eight quarters, with an average year-over-year change of +9.44 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2025 (a gain of 54.83 percentage points); the worst was Q3 2023 (a drop of 46.60 percentage points).
  • Per Business Quant data, ENTX's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -96.54% (Q1 2026), -79.74% (Q4 2025) and -64.06% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Entera Bio 563.51 Mn 269.58 Mn - -12.60%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -12.60%
Jun 30, 2026 -101.40%
Mar 31, 2026 -96.30%
Dec 31, 2025 -79.53%
Sep 30, 2025 -63.80%
Jun 30, 2025 -56.36%
Mar 31, 2025 -72.96%
Dec 31, 2024 -130.18%
Sep 30, 2024 -118.89%
Jun 30, 2024 -97.38%
Mar 31, 2024 -88.46%
Dec 31, 2023 -97.98%
Sep 30, 2023 -133.67%
Jun 30, 2023 -114.35%
Mar 31, 2023 -104.80%
Dec 31, 2022 -100.19%
Sep 30, 2022 -87.07%
Jun 30, 2022 -75.72%
Mar 31, 2022 -62.86%
Dec 31, 2021 -50.09%
API Access

Entera Bio Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ENTX&period=max&api_key=YOUR_API_KEY